CNS Glial Progenitors and Schwann Cells in Neurofibromatosis Type 1

Nancy Ratner,Shyra J. Miller,Bowen Ling,Yuan Huang,Michael Bennett,Randall D. McKinnon,Tilat A. Rizvi

DOI: https://doi.org/10.1046/j.1471-4159.81.s1.48_2.x

2002-01-01

Journal of Neurochemistry

Abstract:Neurofibromatosis type 1 (NF1) one of the most common of all autosomal dominant disorders, affecting about 1 in 3500 individuals. NF1 is considered to be a tumor suppressor disease, in which lack of the NF1 gene product causes disease. NF1 predisposes patients to central nervous system dysfunction including learning disabilities and brain tumors, to bright spots on MRI scans, postulated to be nests of dysmyelination, and to peripheral nerve tumors, both benign and malignant. Glial abnormalities might account for some or all of these defects. To test this, we prepared cultures from spinal cords of embryonic day 12.5 mouse embryos with NF1 mutations. The data show that glial progenitors, both O2A cells and glial restricted progenitors (GRPs) are dramatically amplified in cultures from mutant mice spinal cords, as compared to cultures from wild type littermates. Cells with a single mutant allele show an intermediate phenotype; signalling pathway defects including elevated Ras‐GTP appear to cause the increased cell number. Schwann cells cultured from NF1 mutant E12.5 dorsal root ganglia are also highly abnormal. Mutant Schwann cells differentially express the epidermal growth factor receptor protein (EGFR). EGFR was tested for ability to drive tumor formation in transgenic mice‐ CNPase‐EGFR mice show nerve thickening, consistent with early tumor formation. The data are consistent with a key role for glial cells in brain and peripheral nerve dysfunction in NF1. Acknowledgements: Supported by NIH‐NS28840, the DOD Program on Neurofibromatosis, and the NMSS.